The Day - FDA restricts J&J's COVID-19 vaccine due to blood clot risk - News from southeastern Connecticut

U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to the ongoing risk of rare but serious

Related Keywords

United States ,Washington ,Americans ,Peter Marks ,Johnson ,Centers For Disease ,Pfizer ,Astrazeneca ,Drug Administration ,Disease Control ,New Brunswick ,New Jersey Based ,Epidemics And Pandemics ,Vaccines ,Us Food And Drug Administration ,Ohnson And Johnson , ,